50岁以下的女性应该接受乳腺癌筛查吗？
Should women under 50 be screened for breast cancer?
作者信息
Moss S
机构信息
Institute of Cancer Research Cancer Screening, Evaluation Unit Block D, 15 Cotswold Road, Suuton, Surrey SM52 5NG, UK.
出版信息
Br J Cancer. 2004 Aug 2;91(3):413-7. doi: 10.1038/sj.bjc.6601966.
Abstract
Despite some controversy in recent years, the majority of experts agree on the evidence for effectiveness of breast screening by mammography for women aged 50 years and above, but for those under 50 years, the picture is much less clear. However, the issue remains of importance both to policy makers and to individual women; although the incidence of breast cancer is lower at younger ages, the life years lost due to cancers diagnosed below 50 years amount to a third of all those lost due to the disease.
摘要
尽管近年来存在一些争议，但大多数专家认同乳腺钼靶筛查对50岁及以上女性有效的证据。但对于50岁以下的女性，情况则不太明朗。然而，这个问题对政策制定者和女性个体都依然至关重要；虽然年轻女性患乳腺癌的发病率较低，但50岁以下确诊癌症导致的寿命损失占因该疾病导致的所有寿命损失的三分之一。
相似文献
1
Should women under 50 be screened for breast cancer?
Br J Cancer. 2004 Aug 2;91(3):413-7. doi: 10.1038/sj.bjc.6601966.
2
Screening mammography and public health policy: the need for perspective.
Lancet. 1995 Jul 1;346(8966):29-32. doi: 10.1016/s0140-6736(95)92655-0.
3
Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.
Ann Intern Med. 2011 Jul 5;155(1):10-20. doi: 10.7326/0003-4819-155-1-201107050-00003.
4
A systematic assessment of benefits and risks to guide breast cancer screening decisions.
JAMA. 2014 Apr 2;311(13):1327-35. doi: 10.1001/jama.2014.1398.
5
Screening and prevention of breast cancer in primary care.
Prim Care. 2009 Sep;36(3):533-58. doi: 10.1016/j.pop.2009.04.003.
6
Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography.
J Natl Cancer Inst. 2014 May 28;106(6):dju092. doi: 10.1093/jnci/dju092. Print 2014 Jun.
7
Retrospective cost-effectiveness analysis of screening mammography.
J Natl Cancer Inst. 2006 Jun 7;98(11):774-82. doi: 10.1093/jnci/djj210.
8
Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
CMAJ. 2001 Feb 20;164(4):469-76.
9
Swiss Medical Board Mammography screening predictions for Switzerland: importance of time-periods.
J Med Screen. 2015 Dec;22(4):201-6. doi: 10.1177/0969141315586639. Epub 2015 May 27.
10
Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
Ont Health Technol Assess Ser. 2007;7(1):1-32. Epub 2007 Jan 1.
引用本文的文献
1
Annual mammography at age 45-49 years and biennial mammography at age 50-69 years: comparing performance measures in an organised screening setting.
Eur Radiol. 2019 Oct;29(10):5517-5527. doi: 10.1007/s00330-019-06050-w. Epub 2019 Mar 18.
2
Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.
Adv Exp Med Biol. 2016;882:33-68. doi: 10.1007/978-3-319-22909-6_2.
3
Comprehensive cancer screening among unmarried women aged 40-75 years: results from the cancer screening project for women.
J Womens Health (Larchmt). 2009 Apr;18(4):451-9. doi: 10.1089/jwh.2008.1046.
4
How does age affect baseline screening mammography performance measures? A decision model.
BMC Med Inform Decis Mak. 2008 Sep 21;8:40. doi: 10.1186/1472-6947-8-40.
本文引用的文献
1
Protocol for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer.
Breast. 2000 Apr;9(2):78-82. doi: 10.1054/brst.2000.0136.
2
Mammography screening: are women really giving informed consent?
J Natl Cancer Inst. 2003 Oct 15;95(20):1508-11. doi: 10.1093/jnci/djg026.
3
The UK breast-screening programme should start at age 47 years.
Lancet. 2003 Jul 19;362(9379):246-7. doi: 10.1016/S0140-6736(03)13922-0.
4
Women need better information about routine mammography.
BMJ. 2003 Jul 12;327(7406):101-3. doi: 10.1136/bmj.327.7406.101.
5
American Cancer Society guidelines for breast cancer screening: update 2003.
CA Cancer J Clin. 2003 May-Jun;53(3):141-69. doi: 10.3322/canjclin.53.3.141.
6
Screening for breast cancer: recommendations and rationale.
Ann Intern Med. 2002 Sep 3;137(5 Part 1):344-6. doi: 10.7326/0003-4819-137-5_part_1-200209030-00011.
7
The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years.
Ann Intern Med. 2002 Sep 3;137(5 Part 1):305-12. doi: 10.7326/0003-4819-137-5_part_1-200209030-00005.
8
Radiation doses in the UK trial of breast screening in women aged 40-48 years.
Br J Radiol. 2002 Apr;75(892):362-70. doi: 10.1259/bjr.75.892.750362.
9
Long-term effects of mammography screening: updated overview of the Swedish randomised trials.
Lancet. 2002 Mar 16;359(9310):909-19. doi: 10.1016/S0140-6736(02)08020-0.
10
Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer.
J Epidemiol Biostat. 2001;6(5):365-9; discussion 371-5.
Zotero 插件